As Vice President, Scientific Strategy and Commercial Development, Dr. Rusch identifies scientifically compelling drug development trends aligned to Celerion’s commercial offerings. Dr. Rusch constantly evaluates new offerings for Celerion to drive its evolution and innovation as a life sciences service leader, specializing in the early clinical research space of drug development. Lorraine trained in biology as an undergraduate, received a master’s degree in clinical chemistry, and completed her training as a research fellow in the Cleveland Clinic’s Lerner Foundation with a degree in laboratory medicine and bioanalytical chemistry (Cleveland State University).